Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Health Focus.
State Visit from Iceland
Government Offices of Sweden
·
March 19, 2025
SWEDEN, March 19 - On 6–8 May 2025, Iceland’s President Halla Tómasdóttir will pay a State Visit to Sweden at the invitation of His Majesty The King. Ms Tómasdóttir will be accompanied by her husband, Björn Skúlason, and representatives of the...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
GlobeNewswire, Inc.
·
March 7, 2025
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays...
VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management
GlobeNewswire, Inc.
·
March 4, 2025
VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- VIVUS, LLC., a biopharmaceutical company committed to the development and...
Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures February 2025
International Committee of the Red Cross
·
March 2, 2025
The Red Cross Field Hospital was established and opened on 9 May 2024, and is implemented in coordination with the Palestine Red Crescent Society and supported by Red Cross Societies of Australia, Austria, Canada, China (Hong Kong branch),...
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
GlobeNewswire, Inc.
·
July 10, 2025
REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda...
Category Intelligence Clinical Trials Market is Projected to Reach USD 106.78 Billion by 2032 | CAGR of 7.1%
EIN Presswire
·
January 24, 2025
CA, UNITED STATES, January 24, 2025 /EINPresswire.com/ -- The clinical trials market is experiencing steady growth, driven by rising demand for innovative therapies across therapeutic areas such as oncology, cardiology, neurology, and infectious...
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
GlobeNewswire, Inc.
·
July 9, 2025
REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
GlobeNewswire, Inc.
·
January 13, 2025
CAMPBELL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs,...
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
GlobeNewswire, Inc.
·
June 25, 2025
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
Aztiq sells Adalvo to EQT
GlobeNewswire, Inc.
·
July 18, 2025
Adalvo was founded in 2018 by Aztiq and is one of the leading business-to-business pharmaceutical companies in Europe EQT will support Adalvo’s next phase of growth, expanding its geographic footprint, and advancing the operational scale-up of the...
Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures December 2024
International Committee of the Red Cross
·
December 24, 2024
A Red Cross and Red Crescent response The Red Cross Field Hospital is implemented in coordination with the Palestine Red Crescent Society and supported by Red Cross Societies of Australia, Austria, Canada, China (Hong Kong branch), Denmark,...
Helvetic Clinics Strengthens Its Leadership in Dental Tourism in Hungary in 2024
EIN Presswire
·
December 11, 2024
Helvetic Clinics, recognized the best dental clinic in Hungary, continues to set the benchmark for excellence in patient care with a strategic expansion in 2024 BUDAPEST, BUDAPEST, HUNGARY, December 11, 2024 /EINPresswire.com/ -- Helvetic...
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
GlobeNewswire, Inc.
·
November 4, 2024
REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK...
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
GlobeNewswire, Inc.
·
November 7, 2024
REYKJAVIK, Iceland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Citi’s...
Oculis to Present at the Stifel 2024 Healthcare Conference
GlobeNewswire, Inc.
·
November 13, 2024
ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be present at...
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
GlobeNewswire, Inc.
·
October 25, 2024
REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
'SELLING SUPERMAN' PREMIERES DIGITALLY NOV 18, A HEARTFELT TALE OF COMIC LEGACY, FAMILY, MENTAL HEALTH, AND REDEMPTION
EIN Presswire
·
November 14, 2024
Comic Book Fans and Documentary Lovers Get the Ultimate Gift This Fall LOS ANGELES, CA, UNITED STATES, November 14, 2024 /EINPresswire.com/ -- On November 18, the highly anticipated four-part documentary series, SELLING SUPERMAN, will be...
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
GlobeNewswire, Inc.
·
October 10, 2024
REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines...
VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland
GlobeNewswire, Inc.
·
October 7, 2024
AMSTERDAM, Oct. 07, 2024 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, today announced the availability of QSIVA® (phentermine and topiramate modified-release) in Sweden, Denmark, Finland, Iceland, Norway, and Poland, making QSIVA...
As Per TNR, The Niche Research, Global Mobile Medical Imaging Market is Expected to Grow at a CAGR of 7.6% from 2024 to 2034, Covering Various Product Type, Imaging Technology, Application, End User and Regions
GlobeNewswire, Inc.
·
October 8, 2024
Wilmington, Delaware, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Mobile medical imaging refers to the use of portable imaging devices that allow healthcare professionals to perform diagnostic imaging at the point of care. This technology includes equipment...